Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Haematologica|June 1, 2023
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-TrialThomas Schroeder, Matthias Stelljes, Maximilian Christopeit, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host DiseaseDaniel Wolff, Michael Schleuning, Stephanie von Harsdorf, et al.
Haematologica|October 14, 2011
Therapy-related myeloid neoplasms following treatment with radioiodineThomas Schroeder, Andrea Kuendgen, Sabine Kayser, et al.
Annals of Hematology|April 9, 2026
Impact of early tacrolimus exposure on outcomes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromesPaul Jäger, Andreas Alexander Ralfs, Felicitas Schulz, et al.
NPJ Digital Medicine|June 2, 2023
Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignanciesMalte Jacobsen, Rahil Gholamipoor, Till A Dembek, et al.
Blood|July 1, 2011
High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantationNicola Gökbuget, Nadezda Basara, Herrad Baurmann, et al.
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Transplantation and Cellular Therapy|October 11, 2020
Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic LeukemiaNico Gagelmann, Rashit Bogdanov, Friedrich Stölzel, et al.
JCO Clinical Cancer Informatics|January 13, 2022
Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic MalignanciesMalte Jacobsen, Pauline Rottmann, Till A Dembek, et al.
Blood|August 5, 2015
Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapyFabian Zohren, Ingmar Bruns, Sabrina Pechtel, et al.
Pageof 18